Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01
Published December 30, 2020 · Recall initiated: December 9, 2020
Summary
FDA records drug Class II recall D-0170-2021, published December 30, 2020 and initiated December 9, 2020. Recalling firm: Akebia Therapeutics dba Keryx Biopharmaceutials, Inc; Status: Terminated; Reported quantity: 2,170 bottles; Lot: Lot Number: 9062, exp. date Feb 2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email if AURYXIA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- AURYXIA
- Manufacturer
- Akebia Therapeutics dba Keryx Biopharmaceutials, Inc
- Distributor
- The product was distributed by two major distributors who further distributed the product nationwide and one specialty pharmacy.
- Lot
- Lot Number: 9062, exp. date Feb 2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAuryxia (ferric citrate) tablets 210 mg* 200 Tablets Rx Only NDC 59922-631-01 Manufactured for and distributedJune 2, 2021
- FDAVasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only, Single Dose Container, SCA PharmaceuticalsDecember 30, 2020
- FDASensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mLDecember 30, 2020
- FDAEKOS Control System (CU) 4.0. UPN 600-40500 The EkoSonic MACH4 Endovascular (EKOS) System consists of a singleDecember 23, 2020
- FDAHLS Set Advanced, Model: BEQ-HLS 7050 USA; HLS Set Advanced 7.0 Product Code/Part Number: 70105.2794 - ProductDecember 23, 2020
- FDAAuryxia (ferric citrate) tablets 210 mg, Rx Only, 200 tablets per bottle, Manufactured for and distributed by:July 22, 2020
Questions about this recall
Was Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01 recalled?
Yes. FDA published recall D-0170-2021 on December 30, 2020. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: AURYXIA.